acrolein has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, S; Bhatnagar, A; Conklin, DJ; Haberzettl, P; Jagatheesan, G; Merchant, ML; Prabhu, SD; Prough, RA; Williams, JD | 1 |
| Marcus, L; Margel, S; Ofarim, M; Ravid, M; Savin, H | 1 |
2 other study(ies) available for acrolein and Cardiac Diseases
| Article | Year |
|---|---|
Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice.
Topics: Acrolein; Animals; Antineoplastic Agents, Alkylating; Blood Pressure; Cyclophosphamide; Echocardiography; Glutathione Transferase; Heart Diseases; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium | 2015 |
Treatment of adverse digitalis effects by hemoperfusion through columns with antidigoxin antibodies bound to agarose polyacrolein microsphere beads.
Topics: Acrolein; Aged; Aged, 80 and over; Antibodies; Biocompatible Materials; Digoxin; Female; Heart Diseases; Hemoperfusion; Humans; Male; Microspheres; Middle Aged; Polymers; Sepharose | 1987 |